Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments

por Hulmi, Juha J., Nissinen, Tuuli A., Penna, Fabio, Bonetto, Andrea
Publicado 2021

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver

por Hentilä, Jaakko, Nissinen, Tuuli A., Korkmaz, Ayhan, Lensu, Sanna, Silvennoinen, Mika, Pasternack, Arja, Ritvos, Olli, Atalay, Mustafa, Hulmi, Juha J.
Publicado 2019

Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?

por Pekkala, Satu, Keskitalo, Anniina, Kettunen, Emilia, Lensu, Sanna, Nykänen, Noora, Kuopio, Teijo, Ritvos, Olli, Hentilä, Jaakko, Nissinen, Tuuli A., Hulmi, Juha J.
Publicado 2019

Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses

por Nissinen, Tuuli A., Hentilä, Jaakko, Penna, Fabio, Lampinen, Anita, Lautaoja, Juulia H., Fachada, Vasco, Holopainen, Tanja, Ritvos, Olli, Kivelä, Riikka, Hulmi, Juha J.
Publicado 2018

Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

por Hulmi, Juha J., Nissinen, Tuuli A., Räsänen, Markus, Degerman, Joni, Lautaoja, Juulia H., Hemanthakumar, Karthik Amudhala, Backman, Janne T., Ritvos, Olli, Silvennoinen, Mika, Kivelä, Riikka
Publicado 2017